» Articles » PMID: 27193020

Highly Individual Patterns of Virus-immune IgG Effector Responses in Humans

Overview
Date 2016 May 20
PMID 27193020
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

IgG responses are fundamental to adaptive immunity and document immunological memory of previous pathogen encounter. While specific antigen recognition is mediated by the variable F(ab')2 domain of IgG, various effector functions become activated via the constant Fcγ part bridging IgG-opsonized targets to FcγR-expressing immune effector cells. Traditionally, neutralizing IgG is considered the most appropriate correlate of protective humoral immunity to viruses. However, evidence is increasing that antiviral IgG mediates protection to viruses via activation of FcγRs. Using a test system allowing quantitative detection of virus-immune IgG able to activate FcγRs, sera of healthy individuals and vaccinees were assessed with regard to two prototypical human pathogenic viruses: measles and human cytomegalovirus. Marked differences in the capacity of individuals to generate FcγRI-, FcγRII- and FcγRIII-activating responses were noted. Comparison of FcγR-activating IgG with neutralizing and ELISA IgG concentrations did not correlate for HCMV and only very poorly for MV. Since neither neutralizing IgG nor overall IgG responses faithfully predict the activation of FcγRs, only the simultaneous quantification of IgGs activating defined FcγRs will aid to delineate individual "immunograms" of virus IgG immunity. Such new multiparametric assessment of antiviral IgG qualities could be instrumental in defining correlates of protection and disease progression.

Citing Articles

Clinical efficacy of prophylactic intravenous immunoglobulin for elderly DLBCL patients with hypogammaglobulinemia in the COVID-19 pandemic era.

Baek D, Song G, Lee H, Do Y, Lee J, Yhim H Front Oncol. 2024; 14:1380492.

PMID: 38715775 PMC: 11075150. DOI: 10.3389/fonc.2024.1380492.


Experimental trials of predicted CD4 and CD8 T-cell epitopes of respiratory syncytial virus.

Qousain Naqvi S, Muhammad S, Guo J, Zafar S, Ali A, Anderson L Front Immunol. 2024; 15:1349749.

PMID: 38629077 PMC: 11018974. DOI: 10.3389/fimmu.2024.1349749.


Safety and immunogenicity of inactivated Rift Valley Fever Smithburn viral vaccine in sheep.

Matsiela M, Naicker L, Khoza T, Mokoena N Virol J. 2023; 20(1):221.

PMID: 37789354 PMC: 10548704. DOI: 10.1186/s12985-023-02180-2.


Maternal antibodies induced by a live attenuated vaccine protect neonatal mice from cytomegalovirus.

Le-Trilling V, Jagnjic A, Brizic I, Eilbrecht M, Wohlgemuth K, Rozmanic C NPJ Vaccines. 2023; 8(1):8.

PMID: 36737485 PMC: 9898546. DOI: 10.1038/s41541-023-00602-4.


Circulating multimeric immune complexes contribute to immunopathology in COVID-19.

Ankerhold J, Giese S, Kolb P, Maul-Pavicic A, Voll R, Goppert N Nat Commun. 2022; 13(1):5654.

PMID: 36163132 PMC: 9513013. DOI: 10.1038/s41467-022-32867-z.


References
1.
Mccullough K, Parkinson D, Crowther J . Opsonization-enhanced phagocytosis of foot-and-mouth disease virus. Immunology. 1988; 65(2):187-91. PMC: 1384912. View

2.
Jegerlehner A, Schmitz N, Storni T, Bachmann M . Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity. J Immunol. 2004; 172(9):5598-605. DOI: 10.4049/jimmunol.172.9.5598. View

3.
Haralambieva I, Simon W, Kennedy R, Ovsyannikova I, Warner N, Grill D . Profiling of measles-specific humoral immunity in individuals following two doses of MMR vaccine using proteome microarrays. Viruses. 2015; 7(3):1113-33. PMC: 4379563. DOI: 10.3390/v7031113. View

4.
Plotkin S, B Gilbert P . Nomenclature for immune correlates of protection after vaccination. Clin Infect Dis. 2012; 54(11):1615-7. PMC: 3348952. DOI: 10.1093/cid/cis238. View

5.
Bonsignori M, Pollara J, Moody M, Alpert M, Chen X, Hwang K . Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene family. J Virol. 2012; 86(21):11521-32. PMC: 3486290. DOI: 10.1128/JVI.01023-12. View